Mirtazapine Tablet, Film Coated
Product Images NDC 71610-100

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 30 mg (71610 0100 15)

Bottle Label 30 mg (71610 0100 15)
Mirtazapine 30 mg film-coated tablets packaging label showing 15 tablets per package. The label includes NDC number 71610-0100-15 and indicates prescription use only. Manufactured by Aurobindo Pharma Limited, repackaged by Aphena Pharma Solutions - Tennessee, LLC.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of mirtazapine shown as a two-dimensional molecular diagram, featuring its fused ring system with nitrogen atoms and a methyl group attached to a piperazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.